Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jan;36(1):188–190. doi: 10.1128/aac.36.1.188

In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.

K Nakata 1, H Maeda 1, A Fujii 1, S Arakawa 1, K Umezu 1, S Kamidono 1
PMCID: PMC189251  PMID: 1317145

Abstract

Sparfloxacin was more potent than other quinolones (tosufloxacin, lomefloxacin, ciprofloxacin, ofloxacin, fleroxacin, enoxacin, and norfloxacin) and as potent as minocycline and doxycycline in activity against Chlamydia trachomatis in vitro and in vivo. Sparfloxacin was more bactericidal than minocycline against C. trachomatis D/UW-3/Cx.

Full text

PDF
188

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aznar J., Caballero M. C., Lozano M. C., de Miguel C., Palomares J. C., Perea E. J. Activities of new quinoline derivatives against genital pathogens. Antimicrob Agents Chemother. 1985 Jan;27(1):76–78. doi: 10.1128/aac.27.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bischoff W. Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. Infection. 1986;14 (Suppl 4):S316–S317. doi: 10.1007/BF01661306. [DOI] [PubMed] [Google Scholar]
  3. Fong I. W., Linton W., Simbul M., Thorup R., McLaughlin B., Rahm V., Quinn P. A. Treatment of nongonococcal urethritis with ciprofloxacin. Am J Med. 1987 Apr 27;82(4A):311–316. [PubMed] [Google Scholar]
  4. Kovacs G. T., Westcott M., Rusden J., Asche V., King H., Haynes S. E., Moore E. K., Hall B. E. A prospective single-blind trial of minocycline and doxycycline in the treatment of genital Chlamydia trachomatis infection in women. Med J Aust. 1989 May 1;150(9):483–485. doi: 10.5694/j.1326-5377.1989.tb136591.x. [DOI] [PubMed] [Google Scholar]
  5. Maeda H., Fujii A., Nakata K., Arakawa S., Kamidono S. In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains. Antimicrob Agents Chemother. 1988 Jul;32(7):1080–1081. doi: 10.1128/aac.32.7.1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nakamura S., Minami A., Nakata K., Kurobe N., Kouno K., Sakaguchi Y., Kashimoto S., Yoshida H., Kojima T., Ohue T. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother. 1989 Aug;33(8):1167–1173. doi: 10.1128/aac.33.8.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Noguera X., Ferrer M., Ortolá E., López-Marín L. Evaluation of doxycycline in the treatment of urethritis and cervicitis caused by Chlamydia trachomatis. Clin Ther. 1986;9 (Suppl A):33–37. [PubMed] [Google Scholar]
  8. Schachter J. Chlamydial infections (third of three parts). N Engl J Med. 1978 Mar 9;298(10):540–549. doi: 10.1056/NEJM197803092981005. [DOI] [PubMed] [Google Scholar]
  9. Shiba K., Saito A., Shimada J., Hori S., Kaji M., Miyahara T., Kusajima H., Kaneko S., Saito S., Ooie T. Renal handling of fleroxacin in rabbits, dogs, and humans. Antimicrob Agents Chemother. 1990 Jan;34(1):58–64. doi: 10.1128/aac.34.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Slaney L., Chubb H., Ronald A., Brunham R. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):1–5. doi: 10.1093/jac/25.suppl_a.1. [DOI] [PubMed] [Google Scholar]
  11. Wise R., Lockley R., Dent J., Webberly M. Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother. 1984 Jul;26(1):17–19. doi: 10.1128/aac.26.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES